上海医科大学肝癌研究所科研人员最近发布一系列最新科研成果，为我国肝癌预防、中晚期肝癌治疗以及术后复发转移防治等提供了最新手段。专家认为，这些成果表明我国肝癌基础及临床研究居世界领先水平。作为最常见的一种恶性肿瘤，肝癌死亡率仅次于胃癌，全国每年至少有１２万 Researchers of the Hepatitis Institute of Shanghai Medical University recently released a series of latest scientific research results, which provided the latest means for prevention of liver cancer, treatment of advanced liver cancer, and prevention and treatment of recurrence and metastasis after operation in China. Experts believe that these results show that the basic and clinical research of liver cancer in China ranks first in the world. As the most common malignancy, liver cancer mortality is second only to gastric cancer, and there are at least 120,000 in the country each year.